Literature DB >> 23729999

Seroprevalence and Molecular Characterisation of Human Hepatitis A virus in Serum Samples of Tunisian Patients with Clinical Symptoms of Viral Hepatitis.

Hakima Gharbi-Khelifi1, Nabil Ben Salem Abid, Abir Beji, Leila Bhiri, Rafik Harrath, Khira Sdiri, Sylviane Billaudel, Virginie Ferre, Mahjoub Aouni.   

Abstract

The aim of the present study was to investigate the seroprevalence of Hepatitis A virus antibodies in patients with clinical symptoms of viral hepatitis and molecular characterization of the detected isolates. The present study deals with the seroprevalence and the genetic diversity of HAV in 400 Tunisian patients presenting in dispensaries (160 patients) and in University Hospitals (240 patients) with hepatitis symptoms between 2006 and 2008. The patients with acute hepatitis were mainly from rural regions. However, the total number of patients was decreased over time. The collected samples were from patients with hepatitis symptoms occurring mainly during January-March (36.7, 26, and 35.5%) and September-December (39.4, 43.4, and 35.5%) during the three years of study, respectively. However, HAV infection was established for only 110 among 400 patients. The detected isolates were clustered within sub-genotype IA. The present study constituted another report of the continued surveillance of HAV infection in the region of Monastir and the molecular characterisation of the detected strains.

Entities:  

Keywords:  Anti-HAV IgM; Hepatitis A virus; RT-PCR; Tunisia

Year:  2012        PMID: 23729999      PMCID: PMC3550819          DOI: 10.1007/s13337-012-0063-6

Source DB:  PubMed          Journal:  Indian J Virol        ISSN: 0970-2822


  37 in total

Review 1.  Epidemiological transition of hepatitis A in India: issues for vaccination in developing countries.

Authors:  P Mathur; N K Arora
Journal:  Indian J Med Res       Date:  2008-12       Impact factor: 2.375

2.  Hepatitis A virus infection in a chimpanzee: duration of viremia and detection of virus in saliva and throat swabs.

Authors:  J I Cohen; S Feinstone; R H Purcell
Journal:  J Infect Dis       Date:  1989-11       Impact factor: 5.226

3.  Molecular epidemiology of human hepatitis A virus defined by an antigen-capture polymerase chain reaction method.

Authors:  R W Jansen; G Siegl; S M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

4.  Molecular epidemiology of hepatitis A virus in Amsterdam, the Netherlands.

Authors:  S M Bruisten; J E van Steenbergen; A S Pijl; H G Niesters; G J van Doornum; R A Coutinho
Journal:  J Med Virol       Date:  2001-02       Impact factor: 2.327

5.  Clinical features and molecular characterization of hepatitis A virus outbreak in a child care center in Thailand.

Authors:  Yong Poovorawan; Apiradee Theamboonlers; Voranush Chongsrisawat; Pojchanad Jantaradsamee; Soontaree Chutsirimongkol; Pisit Tangkijvanich
Journal:  J Clin Virol       Date:  2005-01       Impact factor: 3.168

6.  Epidemiologic patterns of wild-type hepatitis A virus determined by genetic variation.

Authors:  B H Robertson; B Khanna; O V Nainan; H S Margolis
Journal:  J Infect Dis       Date:  1991-02       Impact factor: 5.226

7.  Characterization of the complete genomic sequence of genotype II hepatitis A virus (CF53/Berne isolate).

Authors:  Ling Lu; Karen Z Ching; Vanessa Salete de Paula; Tatsunori Nakano; Gunter Siegl; Manfred Weitz; Betty H Robertson
Journal:  J Gen Virol       Date:  2004-10       Impact factor: 3.891

8.  The persistence of hepatitis A IgM antibody after acute clinical hepatitis A.

Authors:  H W Kao; M Ashcavai; A G Redeker
Journal:  Hepatology       Date:  1984 Sep-Oct       Impact factor: 17.425

Review 9.  HAV infection in chronic liver disease: a rationale for vaccination.

Authors:  Piero L Almasio; Pietro Amoroso
Journal:  Vaccine       Date:  2003-06-02       Impact factor: 3.641

10.  The diverse patterns of hepatitis A epidemiology in the United States-implications for vaccination strategies.

Authors:  B P Bell; C N Shapiro; M J Alter; L A Moyer; F N Judson; K Mottram; M Fleenor; P L Ryder; H S Margolis
Journal:  J Infect Dis       Date:  1998-12       Impact factor: 5.226

View more
  2 in total

1.  Detection and Molecular Characterization of Hepatitis A Virus from Tunisian Wastewater Treatment Plants with Different Secondary Treatments.

Authors:  Imen Ouardani; Syrine Turki; Mahjoub Aouni; Jesús L Romalde
Journal:  Appl Environ Microbiol       Date:  2016-06-13       Impact factor: 4.792

2.  Southern Tunisia: A still high endemicity area for hepatitis A.

Authors:  Houcine Neffatti; Patricia Lebraud; Corinne Hottelet; Jawher Gharbi; Taieb Challouf; Anne-Marie Roque-Afonso
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.